Vulvovaginal mycotic infection and Application site rash

Summary:

Application site rash is reported only by a few people with Vulvovaginal mycotic infection.

The study analyzes which people have Application site rash with Vulvovaginal mycotic infection. It is created by eHealthMe based on 2 people who have Application site rash and Vulvovaginal mycotic infection from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 01, 2023

2 people who have Vulvovaginal Mycotic Infection and Application Site Rash are studied.

What is Vulvovaginal mycotic infection?

Vulvovaginal mycotic infection (vulvovaginal fungal infection) is found to be associated with 905 drugs and 495 conditions by eHealthMe.

What is Application site rash?

Application site rash is found to be associated with 926 drugs and 612 conditions by eHealthMe.

Number of Application site rash in Vulvovaginal mycotic infection reports submitted per year:

Would you have Application site rash when you have Vulvovaginal mycotic infection?

Gender of people who have Vulvovaginal Mycotic Infection and experienced Application Site Rash *:

female: 100 %
male: 0.0 %

Age of people who have Vulvovaginal Mycotic Infection and experienced Application Site Rash *:

Common drugs taken by these people *:

Nizoral: 1 person, 50.00%

Common symptoms for these people *:

Application Site Pain: 2 people, 100.00%
Swelling: 1 person, 50.00%
Application Site Reaction: 1 person, 50.00%
Application Site Discoloration: 1 person, 50.00%
Application Site Dryness: 1 person, 50.00%
Application Site Folliculitis (infection and inflammation of one or more hair follicles at application site): 1 person, 50.00%
Application Site Irritation: 1 person, 50.00%
Application Site Pruritus (application site severe itching of the skin): 1 person, 50.00%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 1 person, 50.00%
Skin Discoloration: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Application site rash?

Check whether Application site rash is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Vulvovaginal mycotic infection (7,550 reports)
Application site rash (13,034 reports)

COVID vaccines that are related to Application site rash:

Common drugs associated with Application site rash:

All the drugs that are associated with Application site rash:

Application site rash (926 drugs)

Common conditions associated with Application site rash:

Pain: 1,419 reports
Quit smoking: 774 reports
High blood pressure: 491 reports
Back pain: 385 reports
Hormone replacement therapy: 348 reports

All the conditions that are associated with Application site rash:

Application site rash (612 conditions)

How the study uses the data?

The study is based on Application site rash and Vulvovaginal mycotic infection, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.